Improve Accountability of Opioid Manufacturers

Last updated: Jan 11, 2020

Details about this bill
Category: Pharmacy Related
Status: Passed
Sponsor: Senator Troy Jackson, Senate 35 - York County
Session: 129
Bill #: LD 793

Position:

Monitoring.

Summary:

This bill prohibits opioid medication manufacturers and distributors from falsely advertising that an opioid medication does not have abuse liability or has a lower abuse liability than another opioid medication; distributing a quantity of opioid medications that is not medically reasonable; or failing to report orders that are not medically reasonable. It establishes a civil violation and authorizes the Attorney General to investigate violations. It creates a fund into which the penalties and fees must be paid.

This legislation applies retroactively to January 1, 1985.

UPDATE 1/11/2020: The bill has been amended and allowed to become law without Governor Mills' signature. The amended law would establish a new opioid product medication registration fee of $250,000 and it increases the annual license fee from $200 to $55,000. In allowing the bill to become law, Governor Mills stated that she has concerns that this new law will lead to increased drug prices for consumers. The Board of Pharmacy will be charged with monitoring these price changes.